HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low expression of claudin-1 and presence of poorly-differentiated tumor clusters correlate with poor prognosis in colorectal cancer.

AbstractBACKGROUND:
Claudins are integral membrane proteins that constitute tight junctions. The aim of this study was to determine the clinical significance of claudin-1 in terms of the cell-cell adhesion, considering the poorly-differentiated tumor component.
PATIENTS AND METHODS:
A total of 344 cases of stage II and III colorectal cancer were enrolled. We evaluated the expression of claudin-1 by immunohistochemistry and the extent of the poorly differentiated component.
RESULTS:
Low expression of claudin-1 was associated with lymphatic involvement, histological differentiation, extent of poorly-differentiated component, reduced disease-free and overall survival. Multivariate analysis indicated that lymph node metastasis, venous involvement and low claudin-1 expression were independent predictors of recurrence, and that lymph node metastasis, venous involvement and low claudin-1 expression were associated with poor survival.
CONCLUSION:
Our study not only showed the significance of low expression of claudin-1 as a predictor of poor prognosis of colorectal cancer but also supported the concept of grading of the poorly-differentiated component.
AuthorsMasatsune Shibutani, Eiji Noda, Kiyoshi Maeda, Hisashi Nagahara, Hiroshi Ohtani, Kosei Hirakawa
JournalAnticancer research (Anticancer Res) Vol. 33 Issue 8 Pg. 3301-6 (Aug 2013) ISSN: 1791-7530 [Electronic] Greece
PMID23898096 (Publication Type: Journal Article)
Chemical References
  • CLDN1 protein, human
  • Claudin-1
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cell Aggregation
  • Cell Differentiation
  • Claudin-1 (metabolism)
  • Colorectal Neoplasms (metabolism, pathology, surgery)
  • Disease-Free Survival
  • Female
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: